Dube Eric M (CIK 1763494) reported 35 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-17). Recent activity: Buy TVTX (95,666 shares), Sell TVTX (63,498 shares), Sell TVTX (28,796 shares), Sell TVTX (3,102 shares), Sell TVTX (270 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 95,666 | $2.2M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 63,498 | $3.9M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 28,796 | $1.8M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 3,102 | $197,422 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 270 | $17,634 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 195,841 | $4.6M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 99,716 | $6.3M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 96,125 | $6.1M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 108,493 | $2.5M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 101,691 | $6.6M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 6,802 | $441,795 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 22,500 | $988,875 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 22,500 | $0 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 64,000 | $0 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 56,815 | $2.3M |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 7,165 | $299,139 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 20 | $853 |
| 2026-04-02 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 60,000 | $927,600 |
| 2026-04-02 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 34,902 | $1.1M |
| 2026-04-02 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 25,098 | $789,583 |
| 2026-02-24 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 60,000 | $927,600 |
| 2026-02-24 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 60,000 | $1.8M |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 113,800 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 66,452 | $2.1M |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 33,635 | $1.1M |
来源：SEC Form 4 申报文件 · 截至 2026-09-17